5-amino-1mq human study (10 mg) Research Peptide – Genuine Peptides 5-Amino-1MQ NNMT Inhibitor Tablets

Standard AOD-9604 Dosing Protocol Typical Dosing Range: Standard Dose: 250-500 mcg per day Clinical Trial Dose: 1 mg (1,000 mcg) per day (most effective in studies) Conservative Start: 250 mcg per day for first week Maintenance Range: 500 mcg per day for sustained protocols Frequency: Once daily, typically before breakfast Timing Rationale: Morning fasted state maximizes fat oxidation potential Cycle Length: 12-24 weeks for body composition protocols Administration Route: Subcutaneous injection (abdomen, thigh, or upper arm) Reconstitution: Bacteriostatic water, standard peptide protocols Note: Clinical trials used oral formulations, but subcutaneous administration is more common in current use due to improved bioavailability

GLP-1 brings together two active ingredients that work on complementary pathways: Semaglutide is a GLP-1 receptor agonist

If response at 300mcg appears minimal after two weeks, increase to 400mcg

Your provider may also recommend hormone testing, particularly if you are over 40 or experiencing symptoms of hormonal imbalance

Epigenetic-metabolic interface analyses in target validation projects